Table 1.
Demographic and baseline data of the patients
| Variable | Intervention (n = 14) |
Control (n = 14) |
P-value* |
|---|---|---|---|
| Male gender (n) | 10 (71.4%) | 13 (92.9%) | 0.32 |
| Age (year) | 58.86 ± 9.41 | 57.14 ± 11.43 | 0.66 |
| Weight (kg) | 77.71 ± 10.02 | 82.17 ± 12.59 | 0.31 |
| Euroscore (Standard score) | 1.86 ± 2.07 | 2.14 ± 1.79 | 0.69 |
| LVEF1 (%) | 50.00 ± 6.79 | 49.23 ± 7.31 | 0.79 |
| Mean ABP2 (mm Hg) | 60.43 ± 15.32 | 64.86 ± 8.82 | 0.35 |
| CVP (cm H2O) | 9.00 ± 3.08 | 7.50 ± 2.82 | 0.19 |
| Baseline sCr level (mg/dl) | 0.81 ± 0.15 | 0.78 ± 0.18 | 0.56 |
| Baseline UNGAL level (ng/ml) | 10.36 ± 8.61 | 10.57 ± 3.54 | 0.93 |
| Baseline CRP level | 0.21 ± 0.12 | 0.32 ± 0.27 | 0.20 |
* P values <0.05 were considered as significant.
1. Left Ventricular Ejection Fraction
2. Arterial Blood Pressure
3. Central Venous Pressure